EXOCAN is a clinical-stage, India’s First exosome based company developing therapeutic technologies for cancer and regenerative medicine. Leveraging a patented and scalable, first-in-class exosome discovery platform, we work in two key areas of targeted cargo delivery to cells and liquid biopsies in cancer.